ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026
Activation of an adaptive antitumor immune response by the polymeric fluoropyrimidine CF10 involves TS/Top1 dual targeting.
Akanksha Behl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.